BCBSM/BCN Dual Header The Record Header Logo

The Record - Insurance Card with the BCBSM/BCN Cross and Shield logo that reads, Blue Cross Blue Shield, Blue Care Network of Michigan. Tagline: Confidence comes with every card. Image of Note boards with paper that has the letters RX on it accompanied by a stethoscope

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

November 2017

Commercial Medical Drug Prior Authorization Program adds a specialty drug

Starting Dec. 1, 2017, one additional specialty drug, as follows, will require prior authorization by Blue Cross Blue Shield of Michigan before it will be covered under a member’s medical benefits.

Drug name

HCPCS code

Kymriah™ (tisagenlecleucel)

J3490/J3590/J9999

Keep in mind that prior authorization is a clinical review approval only, not a guarantee of payment.

You can find prior authorization forms for all physician-administered medications on web-DENIS. When logged in, follow these steps:

  • Click on BCBSM Provider Publications and Resources.
  • Click on Commercial Pharmacy Prior Authorization and Step Therapy forms.
  • Click on Go to the Forms page.
  • Click on Physician administered medications.

We won’t consider requests for coverage until we receive one of the following:

  • Physician-signed medication request form by fax or mail
  • Request uploaded to NovoLogix

Our standard processing time to review requests is 15 days. We’ll review urgent requests within 72 hours.

Here are all the medications that are currently part of the Commercial Medical Drug Prior Authorization Program list:

Drug names

Actemra®

Elelyso™

Krystexxa®

Renflexis™

Acthar® gel

Entyvio™

Kymriah™

Ruconest®

Adagen®               

Exondys 51™

Lemtrada™

Signifor® LAR

Aldurazyme®       

Fabrazyme®

Lumizyme®

Simponi Aria®

Aralast NP™

Firazyr®

Makena®

Soliris®

Aveed®

Flebogamma® DIF

Myobloc®

Spinraza™

Benlysta®

Gammagard Liquid®

Myozyme®

Stelara®

Berinert®

Gammagard® S/D

Naglazyme®

Stelara IV®

Bivigam™

Gammaked®

Nplate®

Synagis®

Botox®

Gammaplex®

Nucala®

Testopel®

Brineura™

Gamunex®

Ocrevus™

Tysabri®

Carimune® NF

Glassia™

Octagam®

Vimizim™

Cerezyme®

Hizentra®

Orencia®

Vpriv®

Cimzia®

HyQvi®

Privigen®

Xeomin®

Cinqair®

Ilaris®

Probuphine®

Xgeva®

Cinryze®

Immune globulin

Prolastin®-C

Xiaflex®

Cuvitruv

Inflectra™

Prolia®

Xolair®

Dysport®

Kalbitor®

Radicava™

Zemaira®

Elaprase®

Kanuma™

Remicade®

Zinplava™

Note: The prior authorization requirement doesn’t apply to Federal Employee Program® members.

Blue Cross reserves the right to change the prior authorization list at any time.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2016 American Medical Association. All rights reserved.